Product
Experimental Group
Aliases
CoronaVac
4 clinical trials
3 indications
Indication
COVID-19Indication
SclerosisIndication
MultipleClinical trial
Safety Observation of the Inactivated SARS-CoV-2 Vaccine (Vero Cell) in Population Aged 18 Years and Older: A Multicenter,Open-label StudyStatus: Completed, Estimated PCD: 2023-01-02
Clinical trial
A Randomized and Controlled Ⅳ Clinical Trial to Evaluate the Immunogenicity and Safety of COVID-19 Vaccine (Vero Cell), Inactivated Co-administrated With EV71 Vaccine (Vero Cell) in Children Aged 3-5 Years OldStatus: Completed, Estimated PCD: 2022-07-14
Clinical trial
Safety Observation of the Inactivated SARS-CoV-2 Vaccine (Vero Cell) in Population Aged 3~17 Years : A Multicenter,Open-label StudyStatus: Completed, Estimated PCD: 2023-03-24
Clinical trial
The Efficacy of Tele Rehabilitation- Based Task-Specific Training for Cognitive Function Improvement in Multiple Sclerosis (MS) PatientsStatus: Active (not recruiting), Estimated PCD: 2024-04-01